STANLEY R LANE

Allopathic & Osteopathic Physicians|Allergy & Immunology MOORESTOWN, NJ NPI 1124040159

General Payments — all program years on this page

$989.16

  • Category: General Payments
  • Program years: PY2018–2019
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2019): $314.60 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2019) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $314.6022

By paying entity

Latest program year (PY2019) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $674.5628
2019 $314.6022

Records — PY2019 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
637861515 Shire North American Group Inc $14.18 03/26/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
637861517 Shire North American Group Inc $11.84 04/23/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
637861519 Shire North American Group Inc $13.29 06/18/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659704817 Novartis Pharmaceuticals Corporation $17.14 01/15/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659704819 Novartis Pharmaceuticals Corporation $13.26 04/09/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659704821 Novartis Pharmaceuticals Corporation $14.20 08/06/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
659704823 Novartis Pharmaceuticals Corporation $13.54 05/14/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670398914 GlaxoSmithKline, LLC. $15.00 02/05/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670829431 GlaxoSmithKline, LLC. $16.74 04/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
670889909 GlaxoSmithKline, LLC. $15.72 07/09/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671264285 GlaxoSmithKline, LLC. $13.64 01/09/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
671432443 GlaxoSmithKline, LLC. $13.75 03/11/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685151707 AstraZeneca Pharmaceuticals LP $14.25 08/13/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685571337 AstraZeneca Pharmaceuticals LP $13.08 05/07/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
685853813 AstraZeneca Pharmaceuticals LP $12.29 06/11/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
692224141 Octapharma USA, Inc. $18.52 08/27/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
692588733 Grifols USA, LLC $12.74 05/28/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
693187959 Kaleo, Inc. $14.98 09/10/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
694281083 GENZYME CORPORATION $15.00 04/16/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
694301323 GENZYME CORPORATION $15.00 07/23/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700141459 Boehringer Ingelheim Pharmaceuticals, Inc. $12.95 07/30/2019 Food and Beverage Undisputed 01/23/2026 View at CMS
700141461 Boehringer Ingelheim Pharmaceuticals, Inc. $13.49 01/22/2019 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.